Bestaande gebruiker? Log in
Abonneren
Home
Beurs vandaag
Koersen
Nieuws
Agenda
Analisten
Analisten vandaag
Meest aanbevolen aandelen
Minst aanbevolen aandelen
Aandelen met grootste potentieel
Insider trading
Insiders vandaag
Meest gekochte aandelen
Meest verkochte aandelen
Mijn Trivano
Mijn Trivano
Mijn selecties
Abonneren
Beurs vandaag
Koersen
Nieuws
Agenda
Analisten
Insider trading
Mijn Trivano
Registreren / inloggen
Trivano
Alles over “Medische/verpleegkundige diensten”
Aandelen in “Medische/verpleegkundige diensten”
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
#
Aandeel
Datum
Koers
Evolutie
Even geduld...
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
#
Nieuws over “Medische/verpleegkundige diensten”
Toon enkel gratis nieuws
13/05 ·
Castle Biosciences to Present at the 2026 Jefferies Global Healthcare Conference
· Persbericht
13/05 ·
Castle Biosciences to Present at the 2026 Jefferies Global Healthcare Conference
· Persbericht
12/05 ·
Castle Biosciences' AdvanceAD-Tx™ Test Receives 2026 MedTech Breakthrough Award for Genomics Innovation
· Persbericht
7/05 ·
RAMSAY SANTE : Unaudited interim results at end March 2026
· Persbericht
7/05 ·
DaVita Inc. to Participate in the BofA Securities 2026 Health Care Conference
· Persbericht
6/05 ·
Castle Biosciences Reports First Quarter 2026 Results
· Persbericht
6/05 ·
Option Care Health Investigation Initiated: Levi & Korsinsky Investigates the Officers and Directors of Option Care Health (OPCH)
· Persbericht
5/05 ·
DaVita Inc. 1st Quarter 2026 Results
· Persbericht
5/05 ·
Sadness This Mother's Day? VITAS® Healthcare Launches Free, Nationwide Mother's Day Grief Helpline
· Persbericht
5/05 ·
Fresenius Medical Care delivers strong operating income growth in Q1 2026 while advancing the U.S. rollout of 5008X CAREsystems at speed
· Persbericht
5/05 ·
Castle Biosciences Supports Nationwide Patient Advocacy and Screening Initiatives to Celebrate Skin Cancer Awareness Month
· Persbericht
4/05 ·
New Data at DDW 2026 Show TissueCypher® Testing Improves Risk Stratification and Drives Risk-Aligned Management in Barrett's Esophagus
· Persbericht
29/04 ·
Concord Medical Files Annual Report on Form 20-F for the Fiscal Year 2025
· Persbericht
21/04 ·
Castle Biosciences to Present New Data Demonstrating DecisionDx®-Melanoma's Ability to Identify Patients with Greater Risk of Recurrence and Poor Outcomes Within Early-Stage Melanoma at EADO and ACMS
· Persbericht
21/04 ·
RAMSAY SANTE : Half-year Financial Report as at end of December 2025 disposal
· Persbericht
20/04 ·
DaVita Inc. Schedules 1st Quarter 2026 Investor Conference Call
· Persbericht
10/04 ·
Castle Biosciences Earns 2026 USA TODAY Top Workplaces Award for Fifth Consecutive Year
· Persbericht
27/03 ·
Castle Biosciences' DecisionDx®-Melanoma Test Significantly Improves Risk Prediction Within AJCC Stages to Support Personalized, Risk-Aligned Management of Cutaneous Melanoma, Data to Be Presented at AAD 2026
· Persbericht
24/03 ·
Verana Health and Guardant Health Partner to Advance Precision Medicine with Real-World Data
· Persbericht
18/03 ·
DaVita Highlights Continued Progress in Value-Based Kidney Care as CKCC Results Show Year-Over-Year Improvement
· Persbericht
16/03 ·
Now Open: VITAS® Healthcare Inpatient Hospice Care at Oak Manor
· Persbericht
Mijn selecties
Voorbeeldselectie
Je selectie is nog leeg.
Voeg nu effecten toe